Nasal NO in cystic fibrosis is associated with CFTR genotype, pseudomonas colonization and fatty acids

C. Keen, A. C. Olin, A. Edentoft, E. Gronowitz, B. Strandvik (Gothenburg, Sweden)

Source: Annual Congress 2005 - Cystic fibrosis: genes, inflammation and more
Session: Cystic fibrosis: genes, inflammation and more
Session type: Thematic Poster Session
Number: 2580
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Keen, A. C. Olin, A. Edentoft, E. Gronowitz, B. Strandvik (Gothenburg, Sweden). Nasal NO in cystic fibrosis is associated with CFTR genotype, pseudomonas colonization and fatty acids. Eur Respir J 2005; 26: Suppl. 49, 2580

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth
Source: Eur Respir J 2015; 46: 1033-1045
Year: 2015



Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis
Source: Eur Respir J 2007; 30: 286-292
Year: 2007



Fungal colonization in cystic fibrosis – correlating variables
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019

Polymorphisms of the IL-10 gene and pseudomonas aeruginosa infection in patients with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 717s
Year: 2006

Bacterial infection and lung function in patients with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 615s
Year: 2005

Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa
Source: Eur Respir J 2003; 22: 503-506
Year: 2003



Temporal progression of fungal microbiota in patients with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015


Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 379s
Year: 2002

Cystic fibrosis
Source: Respipedia Article
Year: 2018

Nasal potential difference of carriers of the W493R ENaC variant with non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2016; 47: 322-324
Year: 2016


Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis
Source: Eur Respir J 2005; 26: 651-656
Year: 2005



Emerging pathogens in cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=66
Year: 2006

Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence
Source: Eur Respir J 2001; 17: 27-35
Year: 2001



Amino acid concentration in bronchoalveolar lavage of young children with cystic fibrosis. A target for preventing colonisation with pseudomonas aeruginosa?
Source: Eur Respir J 2006; 28: Suppl. 50, 483s
Year: 2006

Atypical cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=38
Year: 2006

Interleukin-6 gene variants are associated with early Pseudomonas infection in cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 727s
Year: 2005

Host specificity of pseudomonas aeruginosa isolates from patients with cystic fibrosis and patients from different clinical backgrounds
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014


Airway bacterial colonization is associated with low vitamin D serum levels in children with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens
Source: Eur Respir Rev, 28 (152) 190041; 10.1183/16000617.0041-2019
Year: 2019